12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced significant movements. First Wave BioPharma (FWBI) saw a notable increase of 40.8%, while Strata Skin Sciences (SSKN) led the decliners with a 12.6% drop. Other gainers included Bone Biologics (BBLG), Biolase (BIOL), Qilian Intl Hldg Gr (QLI), Agile Therapeutics (AGRX), and Bullfrog AI Hldgs (BFRG). Losers comprised Sientra (SIEN), Ocugen (OCGN), ENDRA Life Sciences (NDRA), Onconetix (ONCO), and SCYNEXIS (SCYX). Market caps varied, with Ocugen having the highest at $159.0 million.
January 02, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Agile Therapeutics' stock rose by 5.97% to $1.95, with a market cap of $4.8 million.
The after-market rise for AGRX may indicate a positive investor outlook, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Bone Biologics' stock increased by 7.72% to $4.46, with a market cap of $2.3 million.
The rise in BBLG's stock price may continue into the next trading session, reflecting positive investor response.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Bullfrog AI Hldgs' stock price went up by 5.24% to $3.15, with a market cap of $19.1 million.
BFRG's stock price increase suggests a positive market reaction that could carry over into the next trading day.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Biolase saw its stock price rise by 6.48% to $1.15, with a market cap of $3.9 million.
Biolase's after-market gains could suggest a bullish trend for the short term, driven by investor optimism.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
First Wave BioPharma's stock soared by 40.8% in after-market trading, with a market cap of $3.6 million.
The significant after-market gain for FWBI suggests positive investor sentiment which could lead to a short-term price increase.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Qilian Intl Hldg Gr's shares increased by 6.4% to $0.68, with a market cap of $24.3 million.
QLI's positive movement in after-market trading could signal a continuation of this trend in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
ENDRA Life Sciences saw a 5.67% decrease in its stock to $1.5, with a market cap of $12.6 million.
The decline in NDRA's stock price could be indicative of negative market sentiment, potentially leading to further short-term losses.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Ocugen's shares fell by 5.72% to $0.62, with a market cap of $159.0 million.
OCGN's after-market decline may suggest a bearish sentiment that could affect its short-term stock performance.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Onconetix's stock decreased by 4.99% to $0.19, with a market cap of $4.2 million.
ONCO's after-market drop could signal a negative investor outlook, possibly affecting its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
SCYNEXIS' stock price fell by 4.98% to $2.1, with a market cap of $78.1 million.
The decrease in SCYX's stock price may continue into the next session, reflecting a bearish trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Sientra's stock declined by 6.42% to $0.6, with a market cap of $7.2 million.
The drop in SIEN's stock price could reflect investor concern, potentially leading to a short-term negative trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Strata Skin Sciences experienced a 12.6% decline in its stock price during after-market hours, with a market cap of $16.4 million.
The notable after-market drop for SSKN could reflect negative investor sentiment, potentially leading to a short-term downtrend.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100